-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Sempra, Lowers Price Target to $103

Benzinga·07/09/2026 13:52:14
Listen to the news
Barclays analyst Nicholas Campanella maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $105 to $103.